Quick answer: how to qualify for Ozempic comes down to one diagnosis: type 2 diabetes in an adult. That is the only population on the FDA label, which covers blood sugar control and, in people with type 2 diabetes, lower heart and kidney risks.[1] Insurers usually also want lab proof, such as an A1C of 6.5% or higher, and sometimes a metformin trial first.[4] If you want semaglutide for weight loss, the approved product is Wegovy, which plans typically cover at a BMI of 30, or 27 with a weight-related condition.[2][6]
Prices and program terms checked October 2026. They change often; confirm with the manufacturer or your plan.
Ozempic and Wegovy both contain semaglutide. They differ in approved uses, doses and how insurers treat them.
Who the Ozempic label covers
The FDA label approves Ozempic for adults with type 2 diabetes:[1]
| Use | Who qualifies |
|---|---|
| Blood sugar control | Adults with type 2 diabetes, with diet and exercise |
| Heart risk reduction | Adults with type 2 diabetes and established cardiovascular disease |
| Kidney protection | Adults with type 2 diabetes and chronic kidney disease |
These uses rest on large trials. In SUSTAIN-6, heart attack, stroke or cardiovascular death occurred in 6.6% of people with type 2 diabetes on semaglutide versus 8.9% on placebo.[7] In FLOW, semaglutide lowered the risk of major kidney events by 24% in people with type 2 diabetes and chronic kidney disease.[8]
Ozempic is not for type 1 diabetes.[5] The American Diabetes Association’s 2026 Standards of Care include GLP-1 receptor agonists among recommended options for type 2 diabetes, particularly for people with heart disease, kidney disease or weight goals.[3]
What insurers ask for
Most plans require prior authorization for Ozempic. Published policies show what that involves.
A confirmed diagnosis. Aetna and the Blue Cross Blue Shield Federal Employee Program both accept one of these results:[4][5]
- A1C of 6.5% or higher
- fasting plasma glucose of 126 mg/dL or higher
- 2-hour glucose of 200 mg/dL or higher on an oral glucose tolerance test
- high-blood-sugar symptoms with a random glucose of 200 mg/dL or higher
A reason for Ozempic specifically. Aetna also requires one of: a poor response to, side effects from, or a medical reason not to take metformin; an A1C of 7.5% or higher on combination therapy; established heart disease; chronic kidney disease; or fatty liver disease.[4]
No overlap. Plans do not cover two GLP-1 drugs at once.[5]
For plan-by-plan detail, see does insurance cover Ozempic, does Aetna cover Ozempic and does BCBS cover Ozempic.
Who should not take Ozempic
The label says Ozempic should not be used by people with:[1]
- a personal or family history of medullary thyroid cancer, or multiple endocrine neoplasia type 2 (MEN 2)
- a known serious allergic reaction to semaglutide or any ingredient
It carries a boxed warning about thyroid C-cell tumors seen in rodents. Tell your clinician about any history of pancreatitis, gallbladder disease, diabetic eye disease or kidney problems, and about pregnancy plans.[1]
Ozempic for weight loss: the off-label question
Doctors may legally prescribe an approved drug for an unapproved use. That is called off-label prescribing. But for Ozempic and weight loss:
- Insurers usually will not pay. FEP Blue considers Ozempic investigational for anything other than its diabetes criteria.[5]
- An approved alternative exists. Wegovy is the same drug, approved for weight reduction in adults with obesity, or overweight with at least one weight-related condition, and in children 12 and older with obesity.[2]
- Savings programs follow the label. Novo Nordisk’s savings offer requires a prescription for an approved use.[11]
Wegovy criteria if your goal is weight loss
Wegovy’s label does not set a BMI number, but insurers usually mirror the entry criteria of the STEP trials: a BMI of 30 or more, or 27 or more with at least one weight-related condition such as high blood pressure or high cholesterol.[6] In STEP 1, adults on semaglutide 2.4 mg lost 14.9% of body weight over 68 weeks, versus 2.4% on placebo.[6]
Plans also commonly require a lifestyle program and 5% weight loss to renew. Wegovy is approved for heart risk reduction and MASH too.[2] Medicare’s GLP-1 Bridge uses its own BMI tiers, starting at 35, or lower with conditions such as prediabetes or heart failure.[12]
See our Wegovy prior authorization guide and does insurance cover Wegovy.
How to talk to your doctor
- Bring numbers. Recent A1C or glucose results, weight, height and blood pressure.
- List your conditions. Heart disease, kidney disease, fatty liver, sleep apnea and prediabetes can all affect which drug fits and what insurance will cover.
- Share your medicine history. Include metformin or other diabetes or weight-loss drugs, and why you stopped.
- Ask which drug matches your diagnosis. Ozempic for type 2 diabetes, Wegovy for weight management or heart risk, or another option.
- Ask how success will be measured. For diabetes, that is usually A1C every few months; for weight management, the percentage of weight lost.
- Ask about cost. Your clinician’s office can check prior authorization requirements before you fill. The prescriber also sets your starting dose and how it increases.[1]
If cost is the barrier
- Commercial insurance: the Ozempic savings offer can lower your copay to as little as $25.[11]
- Low income, uninsured: Novo Nordisk’s Patient Assistance Program covers Ozempic for uninsured people with household income at or below 200% of the federal poverty level who meet its rules.[10]
- Medicare or Medicaid: see does Medicare cover Ozempic and does Medicaid cover Ozempic.
- No coverage: compare self-pay prices in how to get semaglutide without insurance.
